ANLON HEALTHCARE LIMITED
₹ 86 - ₹ 91
26-Aug-2025 - 29-Aug-2025
₹ 14924.00

/ 164 Shares

ANLON HEALTHCARE LIMITED

26-Aug-2025 - 29-Aug-2025

₹ 86 - ₹ 91

Price Band

₹ 14924.00

Minimum Investment

164

Bid Lot

13,300,000

Shares
  • Face Value - ₹ 10/- Per Share

  • Listing at BSE, NSE

  • 8,109 Application Required in Retail for 1 Time.

  • Registrar : KFin Technologies Limited

IPO Details

Category % Shares/Amount
QIB 75% 9,975,000 Shares RS.90.77 CR
HNI 1 5% 665,000 Shares RS.6.05 CR @ 290 FORM 1X
HNI 2 10% 1,330,000 Shares RS.12.10 CR @ 579 FORM 1X
Retail 10% 1,330,000 Shares RS.12.10 CR @ 8110 FORM 1X

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
8110 FORM 1X 290 FORM 1X 579 FORM 1X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 164 ₹ 14,924
Retail (Upto 2 Lakh) 13 2132 ₹ 194,012
S-HNI (2 Lakh to 10 Lakh) 14 2296 ₹ 208,936
S-HNI (2 Lakh to 10 Lakh) 67 10988 ₹ 999,908
B-HNI (Above 10 Lakh) 68 11152 ₹ 1,014,832

IPO Timeline

  • Open Date

    26-Aug-2025
  • Close Date

    29-Aug-2025
  • Basis of Allotment Date

    01-Sep-2025
  • Initiation of Refunds

    02-Sep-2025
  • Credit Shares to Demat A/c

    02-Sep-2025
  • IPO Listing Date

    03-Sep-2025

About Company

Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).

The company manufactures high-purity pharmaceutical intermediates (for API production) and active pharmaceutical ingredients (used in formulations for medicines, nutraceuticals, personal care, and animal health products).

The company offers pharmaceutical intermediates, APIs for medicines, nutraceuticals, personal care, and veterinary products, all manufactured following Indian and international pharmacopeia standards like IP, BP, EP, JP, and USP.

In addition to manufacturing Pharma Intermediates and APIs to global standards, the company now offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities to meet specific customer needs.

The company has received Drug Master File (DMF) approval from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs. The company has filed 21 DMFs with global authorities and is in the process of filing for Ketoprofen and Dexketoprofen Trometamol approvals.

The company’s portfolio includes 65 commercialized products, 28 at the pilot stage, and 49 in laboratory testing.

The company ensures product quality through rigorous testing, analysis, and process improvements. Supported by four labs, the 34-member team, including 24 science graduates, ensures products meet customer and industry standards.

Products:

  • Pharma Intermediates:Cyanoethylbe nzoic acid, Ketonitrile and Methyldeslor atadine, these serve as a key starting material or as an advance intermediate for manufacturing of APIs.
  • Active Pharmaceutical Ingredients: The company’s APIs are key components in pharmaceutical products, delivering therapeutic effects. They are used in formulations like tablets, capsules, ointments, syrups, and in nutraceuticals, personal care, and veterinary products.

As of January 31, 2025, the company had 105 employees (excluding trainees) and 8 contract workers.

Read More

Strengths

Competitive Strengths:

  • Strong product portfolio and scalable business.
  • Strong Promoters and Experienced Management Team.
  • High entry and exit barriers due to long customer approval cycles and strict product standards.
  • In-house Testing, Quality Control and Quality Assurance for quality control.
  • Focus on Quality, Environment, Health and Safety.

Company Promoters

Company Financials

Period Ended 31 Jan 2025 31 Mar 2024 31 Mar 2023 31 Mar 2022
Assets 160.96 128 111.55 84.97
Total Income 77.37 66.69 113.12 57.54
Profit After Tax 11.96 9.66 5.82 -0.11
Net Worth 71.86 21.03 7.37 1.55
Reserves and Surplus 32.01 5.03 -4.63 -10.24
Total Borrowing 62.39 74.56 66.39 60.32
Amount in ? Crore

Objects of the Issue

The Company Anlon Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No. Objects of the Issue Expected Amount (in Millions)
1 Funding capital expenditure requirements for Proposed Expansion 3,071.95
2 Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company 500
3 Funding the working capital requirements of the Company 4,315
4 General corporate purposes

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to Us.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with Us, in just a few clicks your application is processed. You can bid for any IPO through Us, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Apply Now